Bristol-Myers Squibb Company
BMY
$45.95
$0.591.30%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 12.27B | 11.20B | 12.34B | 11.89B | 12.20B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.27B | 11.20B | 12.34B | 11.89B | 12.20B |
| Cost of Revenue | 3.36B | 3.02B | 3.21B | 2.86B | 2.97B |
| Gross Profit | 8.91B | 8.18B | 9.13B | 9.04B | 9.23B |
| SG&A Expenses | 1.69B | 1.58B | 1.85B | 2.08B | 1.92B |
| Depreciation & Amortization | 830.00M | 830.00M | 1.69B | 2.41B | 2.42B |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.14B | 7.67B | 9.55B | 9.70B | 9.60B |
| Operating Income | 4.13B | 3.54B | 2.80B | 2.20B | 2.60B |
| Income Before Tax | 1.77B | 2.97B | 175.00M | 1.68B | 1.29B |
| Income Tax Expenses | 460.00M | 509.00M | 99.00M | 461.00M | -398.00M |
| Earnings from Continuing Operations | 1.31B | 2.46B | 76.00M | 1.22B | 1.68B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -2.00M | -6.00M | -4.00M | -4.00M | -4.00M |
| Net Income | 1.31B | 2.46B | 72.00M | 1.21B | 1.68B |
| EBIT | 4.13B | 3.54B | 2.80B | 2.20B | 2.60B |
| EBITDA | 5.11B | 4.55B | 4.65B | 4.83B | 5.19B |
| EPS Basic | 0.64 | 1.21 | 0.04 | 0.60 | 0.83 |
| Normalized Basic EPS | 1.30 | 1.14 | 0.76 | 0.72 | 0.84 |
| EPS Diluted | 0.64 | 1.20 | 0.04 | 0.60 | 0.83 |
| Normalized Diluted EPS | 1.30 | 1.13 | 0.75 | 0.72 | 0.84 |
| Average Basic Shares Outstanding | 2.04B | 2.03B | 2.03B | 2.03B | 2.03B |
| Average Diluted Shares Outstanding | 2.04B | 2.04B | 2.04B | 2.03B | 2.03B |
| Dividend Per Share | 0.62 | 0.62 | 0.62 | 0.60 | 0.60 |
| Payout Ratio | 96.34% | 51.22% | 1,691.67% | 100.41% | 72.44% |